Brain+ A/S (CPH: BRAINP)
Denmark
· Delayed Price · Currency is DKK 0.0820
+0.0070 (9.33%)
Oct 2, 2024, 4:59 PM CET
Brain+ Market Cap
Brain+ has a market cap or net worth of 14.06 million as of October 3, 2024. Its market cap has increased by 6.98% in one year.
Market Cap
14.06M
Enterprise Value
n/a
Revenue
6.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since October 7, 2021, Brain+'s market cap has decreased from 51.99M to 14.06M, a decrease of -72.95%. That is a compound annual growth rate of -35.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2024 | 14.06M | 10.74% |
| Dec 29, 2023 | 12.70M | -37.15% |
| Dec 30, 2022 | 20.21M | -50.00% |
| Dec 30, 2021 | 40.41M | -22.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk A/S | 3,477.74B |
| Coloplast A/S | 196.96B |
| Genmab A/S | 101.20B |
| Zealand Pharma A/S | 57.86B |
| Demant A/S | 56.39B |
| H. Lundbeck A/S | 41.69B |
| H. Lundbeck A/S | 41.69B |
| ALK-Abelló A/S | 37.58B |